KCB-1 protein, recombinant

Controlled delivery of multiple therapeutic agents can be considered as an effective approach in skin tissue engineering. In this… (More)

The incidence of after-cataracts [also known as posterior capsular opacification (PCO)] is between 30% and 50% three years… (More)

Site-specific controlled release of biologically active angiogenic growth factors such as recombinant human basic fibroblast… (More)

Recombinant human basic fibroblast growth factor (rhbFGF) is a peptide with many bioactivities such as promoting proliferation… (More)

BACKGROUND The healing period of bone-implant osseointegration usually varies from 3 to 6 months or even longer. Failure may… (More)

We report the use of topical application of recombinant human basic fibroblast growth factor (rhbFGF) to successfully treat… (More)

Local angiogenic therapy with recombinant human basic fibroblast growth factor (rhbFGF) has been used to promote wound healing… (More)

The effect of local application of recombinant human basic fibroblast growth factor (rhbFGF) on fracture repair was examined… (More)

We examined the in vitro effects of pituitary-derived chicken growth hormone (cGH), recombinant human insulin-like growth factor… (More)

Recombinant human basic fibroblast growth factor (rhbFGF) was found to induce secretion of nerve growth factor (NGF) in cultured… (More)